Based in Spring, TX, Donald Lee “Don” Pferdehirt is a respected leader who has worked in the chemical process sector for more than two decades and now serves clients as a consultant in the field. Outside of his professional life, Don Pferdehirt is a longtime supporter of the Lupus Foundation of Pittsburgh and its work as part of a larger collaborative effort with the Lupus Foundation of America to help those with the disease.
In February 2019, the Lupus Foundation of America unveiled a new partnership with life science company Exagen to increase awareness about major advances in laboratory testing that can lead to a timely diagnosis of Lupus - a key element of effectively treating the disease. Exagen has developed several laboratory tests that give health care providers comprehensive analyses of the key biomarkers in patients who may have systemic lupus erythematosus (SLE) in conjunction with its own algorithm that can predict how likely it is that SLE is actually present in these patients. Accuracy of the test is greater than 80 percent.
LFA and Exagen say they will work together to make sure that patients and medical providers are educated about the specific benefits of these tests. In his comments, LFA president and CEO Stevan W. Gibson says the main goal of the partnership is to cut down on the time it takes to get an accurate diagnosis, which in turn will lead to better patient outcomes